IT IS ALL ABOUT WHO ATTENDS
The reality is that no matter how great the content, speakers, production values, venues, or catering are, the most important thing for sponsors and exhibitors is to meet the right people.
Over the years, we have worked hard to create an audience mix that will deliver the best ROI for our clients. Below, we have tried to be as granular as possible to map out exactly who you can expect to meet at Ai-Med.
TOTAL ATTENDANCE IN 2023
1,293
TOTAL ATTENDANCE IN 2024
1,530
GS24 IS KEEPIING THINGS TIGHT
We're now able to control the number of tickets we sell for each registrant type, so we can curate the audience mix and make sure no one group is overrepresented.
We're also keeping the event size to a cool 1,500 attendees. That's big enough to get a good ROI, but not so big that you get lost in the crowd.
We think this is the perfect size for Ai-Med, and we're excited to see who joins us in 2024!
As a clinician led organization this group plays a vital role in the adoption of AI. We have made the event CME & CNE certified for 2024 to support this audience persona.
We have created 500 passes for this group
Payer / Provider Clinical leaders. These executives are responsible for the clinical aspects of the organization, such as patient care, quality, and safety. Titles include chief medical officer (CMO), chief nursing officer (CNO), and chief quality officer (CQO)
We have created 230 passes for this group
Payer / Provider Administrative leaders. These executives are responsible for the non-clinical aspects of the organization, such as finance, operations, and human resources. Titles include the chief executive officer (CEO), chief financial officer (CFO), and chief operating officer (COO)
We have created 230 passes for this group
Payer / Provider Strategic leaders. These executives are responsible for the long-term vision and strategy of the organization. Titles include the chief strategy officer (CSO), chief innovation officer (CIO), and chief digital officer (CDO)
We have created 230 passes for this group
An important part of our audience and ultimately the future of AI in medicine. We are aware that this group does not have the buying power today and our sponsors and exhibitors are not really coming to meet them. None the less, we care about this group deeply and always love the energy they bring.
We have created 30 passes for this group
This includes vendors, media, legal and consultants. All important stakeholders we just like to control the numbers to keep a good balance.
We have created 200 passes for this group
TESTIMONIAL
AiMED was an impactful and insightful event. Our team felt that we had high-quality discussions on AI deployment with key stakeholders at AiMED23. We look forward to sponsoring the 2024 event.
Karla Sartori, Head of US Marketing, Bayer Radiology Digital Solutions
TESTIMONIAL
It was a great event. I brought one of our cofounders to this meeting and he really enjoyed the event. We are excited to be part of this community and want to grow with the AIMED community as AI becomes more and more prevalent in medicine.
Hannah Chan, MD, MHM, Chief Operating Officer at Skinopathy